{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:00:00Z","timestamp":1785272400134,"version":"3.55.0"},"reference-count":16,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,1,30]]},"published-print":{"date-parts":[[2026,6]]},"DOI":"10.2967\/jnumed.125.271312","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:20:16Z","timestamp":1771521616000},"page":"846-847","source":"Crossref","is-referenced-by-count":0,"title":["Advancing Theranostics in Alzheimer Disease: FDA Approval of Amyloid- PET Drugs for Selection of Patients for Amyloid-\u07d6Directed Therapies and Other Labeling Updates"],"prefix":"10.2967","volume":"67","author":[{"given":"Hayoung","family":"Koo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Mattay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Alex","family":"Hofling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue-Jane","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Krainak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younsook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Krudys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Buracchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libero","family":"Marzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2026060105301017000_67.6.846.1","unstructured":"Leqembi (lecanemab-irmb) prescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761269s013lbl.pdf. Accessed February 2, 2026."},{"key":"2026060105301017000_67.6.846.2","unstructured":"Kisunla (donanemab-azbt) prescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761248s004lbl.pdf. Accessed February 2, 2026."},{"key":"2026060105301017000_67.6.846.3","unstructured":"Amyvid (florbetapir F 18) prescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/202008s046lbl.pdf. Accessed February 2, 2026."},{"key":"2026060105301017000_67.6.846.4","unstructured":"Vizamyl (flutemetamol F 18) prescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/203137s024lbl.pdf. Accessed February 2, 2026."},{"key":"2026060105301017000_67.6.846.5","unstructured":"Neuraceq (florbetaben F 18) prescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/204677s024s034lbl.pdf. Accessed February 2, 2026."},{"key":"2026060105301017000_67.6.846.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"2026060105301017000_67.6.846.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265766"},{"key":"2026060105301017000_67.6.846.8","unstructured":"Amyvid summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/amyvid-epar-product-information_en.pdf. Accessed February 2, 2026."},{"key":"2026060105301017000_67.6.846.9","unstructured":"Neuraceq summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/neuraceq-epar-product-information_en.pdf. Accessed February 2, 2026."},{"key":"2026060105301017000_67.6.846.10","unstructured":"Vizamyl summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vizamyl-epar-product-information_en.pdf. Accessed February 2, 2026."},{"key":"2026060105301017000_67.6.846.11","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13859"},{"key":"2026060105301017000_67.6.846.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.10.007"},{"key":"2026060105301017000_67.6.846.13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-190818","article-title":"Improved risk stratification for progression from mild cognitive impairment to Alzheimers disease with a multi-analytical evaluation of amyloid- positron emission tomography","volume":"74","author":"Beyer","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"2026060105301017000_67.6.846.14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/jamaneurol.2018.0894","article-title":"Use of flutemetamol F 18labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic mild cognitive impairment","volume":"75","author":"Wolk","year":"2018","journal-title":"JAMA Neurol."},{"key":"2026060105301017000_67.6.846.15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-308094"},{"key":"2026060105301017000_67.6.846.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268756"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:18:08Z","timestamp":1785269888000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":16,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.2967\/jnumed.125.271312"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271312","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]}}}